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Edited by Francesc PosasAbstract We investigated why treatment of cells with dual aur-
ora A and B kinase inhibitors produces phenotypes identical to
inactivation of aurora B. We found that dual aurora kinase
inhibitors in fact potently inhibit cellular activities of both ki-
nases, indicating that inactivation of aurora B bypasses aurora
A in mitosis. RNAi experiments further established that inacti-
vation of aurora B indeed bypasses the requirement for aurora
A and leads to polyploidy. Inactivation of aurora A activates
checkpoint kinase BubR1 in an aurora B-dependent manner.
Our results thus show that aurora B is responsible for mitotic
arrest in the absence of aurora A.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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During mitosis, sister chromatids are equally segregated into
two daughter cells. Accurate chromosome segregation requires
precise spatiotemporal coordination of many highly complex
mitotic events [1]. These mitotic events involve DNA conden-
sation, centrosome maturation, bipolar spindle formation,
kinetocore/microtubule attachment, sister chromatid dissolu-
tion and cytokinesis. Recent studies demonstrate that kinases
of the aurora family are critically involved in the control of
these mitotic events [1–3].
The three members of aurora kinase family in mammals
share high structure and sequence similarities [2,3]. However,
they show distinct localizations and functions during mitosis.
Aurora A localizes to centrosomes and proximal regions of
the spindle. Studies in ﬂy and human cells have established
that aurora A is essential for centrosome duplication and mat-
uration, and bipolar spindle formation [2–4]. Interestingly, re-
cent studies on kinetics of a synchronized cell cycle progression
in the absence of aurora A revealed that aurora A also plays an
important role in promoting entry into mitosis of human cells
[5,6]. As a chromosome passenger protein, aurora B ﬁrst asso-
ciates with centromeres at early mitosis, relocates to central
spindle in anaphase and then concentrates at cell cortex where*Corresponding author. Fax: +1 317 276 6510.
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doi:10.1016/j.febslet.2005.04.080contractile ring forms during cytokinesis [2,3,7]. Not surpris-
ingly, aurora B is involved in DNA condensation, chromo-
some bi-orientation, kinetochore-microtubule attachment and
cytokinesis [2,3]. Aurora C is also associated with centrosomes,
but its function in mitosis is not yet known [2,3].
Human aurora A kinase is mapped to the chromosomal re-
gion 20q13.3, which is frequently ampliﬁed in many types of
cancer [2,3,8,9]. Increased activity of aurora A is implicated
in genome instability and tumor progression. Indeed, overex-
pression of aurora A causes genome instability and transforms
NIH-3T3 cells, demonstrating aurora A is a bona ﬁde onco-
gene [8,10,11]. Therefore, aurora A represents a highly attrac-
tive target for anticancer drug discovery [12].
In an eﬀort to develop aurora A kinase inhibitors as antican-
cer agents, we found that most aurora A kinase inhibitors also
have potent activities on aurora B kinase both in vitro and in
vivo. Surprisingly, treatment of cells with inhibitors with dual
aurora kinase activity results in mitotic defects resembling
inactivation of aurora B. We discovered that inactivation of
aurora B bypasses the requirement for aurora A in mitosis,
thus providing a molecular explanation why dual aurora ki-
nase inhibitors do not cause a mitotic arrest but instead, cause
DNA endoreduplication in the absence of cytokinesis, also as
observed previously by others [13–15].2. Materials and methods
2.1. Cell culture and cell-based assay of dual aurora kinase inhibitor
target activity
HeLa, Calu6 and U2OS human cancer cells were obtained from
ATCC and maintained as per ATCC recommendations. Calu6 cells
have a high mitotic index and thus have a higher basal level of phos-
phorylated aurora A and phosphorylated histone H3. Therefore,
Calu6 cells were used to assay cellular target activities described here
for two dual aurora kinase inhibitors ZM447439 and Hesperadin re-
ported recently [13,15]. We chemically synthesized the aurora kinase
inhibitors. Calu6 cells were plated in 6-well plates at 3.5 · 105 cells/well
overnight and then treated with the kinase inhibitors for 1 h. The ﬁnal
concentration of dimethyl sulfoxide (DMSO) was adjusted to 0.5% of
growth medium for all treatments. The levels of phosphorylation of
aurora A and histone H3 were visualized by Western blotting and
quantiﬁed using an Lumi-Imager (Roche) to calculate IC50 values of
aurora kinase inhibitors.
2.2. RNAi and immunoblotting
Commercial siRNA duplexes targeting aurora A, aurora B and
BubR1 were obtained from Dharmacon. The siRNA duplex targeting
TPX2 was made by Dharmacon based on a siRNA sequence previ-
ously described [16]. HeLa and U2OS cells were plated at 0.75 · 105blished by Elsevier B.V. All rights reserved.
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tion. Oligofectamine reagent (Invitrogen) was used to transfect siRNA
into cells, basically following the recommended procedures by Invitro-
gen. Typically 50 nM siRNA oligos along with 4 ll oligofectamine re-
agent for HeLa cells or 3 ll for U2OS cells were used per transfection.
Protein lysates were harvested 24 h after transfection to analyze target
protein knockdown by immunoblotting as described previously [17].
For ﬂow cytometry analysis of DNA contents, cells were collected at
48–72 h after transfections.
2.3. Immunoﬂuoresscence microscopy
HeLa cells were cultured in Lab-Tek 2 chamber slides (Fisher Scien-
tiﬁc) at 0.2 · 105 per chamber. Cells were ﬁxed with cold methanol and
then permeabilized with 0.5% Triton-X 100. After blocking for 1 h at
room temperature with 10% bovine serum albumin (BSA) in 1X
phosphate buﬀer saline (PBS), the chambers were incubated with the
indicated antibodies in 1X PBS with 10% BSA overnight at 4 C
(anti-a-tubulin antibody 1:100 dilution; anti-phospho-histone H3 S10
antibody 1:100 dilution) and then washed with PBST (1X PBS with
0.1% Tween 20) for 3X at 10 min each with shaking. Samples were then
incubated with secondary antibody conjugates with 1:500 dilution for
1 h at room temperature and were washed with PBST as described
above. Finally cells were counterstained with 2 lM 4 0,6-diamidino-2-
phenyindole (DAPI) for 2 min. For mitotic index determination, 500
randomly selected cells were counted for positive staining with the
phosphor-histone H3 S10 antibody.
2.4. Antibodies
The following antibodies were used in this study: rabbit anti-aurora
A and anti-phopspho (T288) aurora A (Cell signaling), mouse anti-
aurora B and anti-BubR1 (BD Biosciences), rabbit anti-phospho-
histone H3 (S10) and mouse anti-cyclin B1 (Upstate Biotechnology),
mouse anti-a-tubulin (Sigma) and rabbit anti-aurora B (Zymed Labo-
ratories). Alexa Fluor 488 anti mouse IgG and Alexa Fluor 568 anti
rabbit IgG were obtained from Molecular Probes. A polyclonal anti-
body to human TPX2 was raised in rabbit against a synthetic peptide
corresponding to amino acids 264–277 of human TPX2 and aﬃnity
puriﬁed by Zymed Laboratories Inc.3. Results
3.1. Dual aurora A and aurora B kinase inhibitors
Most of our aurora A kinase inhibitors identiﬁed through an
aurora A kinase activity-based screen were also found to have
potent activities on aurora B. This dual aurora kinase activity
is consistent with previous reports of aurora inhibitors simi-
larly discovered [13–15] and the fact that aurora A and aurora
B share very high homology in their catalytic domains [2,3].
Intriguingly, treatment of human cells with dual aurora inhib-
itors only inhibits cytokinesis and leads to large polyploid cells,
a terminal phenotype consistent with inactivation of aurora B
but not inactivation of aurora A, although aurora A normally
acts upstream of aurora B during mitosis. It was thus thought
that the dual aurora inhibitors only inhibit aurora B in vivo
[13].
To directly determine whether dual aurora kinase inhibitors
indeed only inhibit aurora B but lack activity on aurora A in
vivo, we analyzed eﬀects of two well-characterized aurora
inhibitors recently reported [13,15] on autophosphorylation
of aurora A at T288 [18,19] and aurora B phosphorylation
of histone H3 at S10 [20,21]. We reasoned that if aurora inhib-
itors only have activity on aurora B, then they should only in-
hibit histone H3 phosporylation at S10; on the other hand, if
they inhibit both aurora A autophosphorylation and histone
H3 phosphorylation, then they must have activity on both aur-
ora kinases in vivo. Western blot analysis showed that the dual
aurora inhibitors potently inhibited both aurora A autophos-phorylation and aurora B phosphorylation of histone H3
(Fig. 1A and B). Therefore, the data show that dual inhibitors
in fact have potent dual aurora activities in vivo. As aurora A
normally acts upstream of aurora B and is essential for pro-
gression through mitosis, results thus indicate that inactivation
of aurora B function might bypass the normal requirement for
aurora A in mitosis.3.2. Inactivation of aurora B function overrides the requirement
for aurora A and TPX2 in mitosis
To further explore this possibility, we employed RNAi to
inactivate aurora A and aurora B individually or in combi-
nation. Western blot analysis showed that siRNAs eﬀectively
and selectively inhibited their target protein expression (Fig.
2A). Cells lacking aurora A had a markedly increased mito-
tic index with an elevated level of cyclin B1 and showed a
variety of spindle defects, with monopolar spindles as the
predominant defect (Fig. 2B-b). By contrast, cells lacking
both aurora A and aurora B did not show an elevated mi-
totic index (Fig. 2C). Instead, they became polyploid and
had multiple nuclei, as previously reported for cells with
inactive aurora B (Fig. 2B and D), suggesting that cells were
able to progress through mitosis in the absence of both aur-
ora A and aurora B. Consistently, the level of cyclin B1 was
markedly decreased in cells lacking both aurora A and aur-
ora B as compared to that of cells lacking aurora A (Fig.
2A).
TPX2 is a regulatory subunit of aurora A kinase [4,10]. We
suspected that inactivation of aurora B would also bypass the
requirement for TPX2. In agreement with previous report [16],
inhibition of TPX2 by RNAi caused a mitotic arrest and sim-
ilar spindle defects as aurora A inactivation. Consistent with a
mitotic arrest in the absence of TPX2 is a marked increase in
the level of aurora B and cyclinB1 proteins and phosphory-
lated histone H3 (Fig. 2A). As expected, inhibition of both
TPX2 and aurora B also generated polyploid cells with >4 N
DNA content (Fig. 2D). Together, the data demonstrates that
inactivation of aurora B function indeed bypasses the require-
ment for aurora A in mitosis.3.3. Bypass of aurora A and subsequent polyploidization by
inactivation of aurora B are independent of p53
Cells that exit mitosis without proper DNA segregation or
cytokinesis normally arrest permanently in a tetraploid state
at G1. This arrest is mediated through a p53 checkpoint
control to prevent polyploidy [22,23]. It was also shown re-
cently that lack of p53 function exacerbates polyploidization
caused by either aurora A overexpression [11] or by treat-
ment with dual aurora kinase inhibitors [13]. As HeLa cells
are p53 deﬁcient, we wondered whether bypassing aurora A
by inactivation of aurora B and subsequent polyploidization
occur only in the absence of p53 function. Therefore, we re-
peated the siRNA knockdown experiment with p53-proﬁ-
cient U2OS cells. Knockdown of aurora A and TPX2 in
U2OS cells also resulted in a mitotic arrest. By contrast,
simultaneous knockdown with aurora B failed to cause mi-
totic arrest and instead, led to polyploidization (>4 N
DNA content) (Fig. 3). The data indicates that inactivation
of aurora B bypasses the requirement for aurora A during
mitosis and promotes subsequent polyploidization indepen-
dent of p53.
Fig. 1. Potent in vivo activities of dual aurora kinase inhibitors in Calu6 cells. (A) In vivo target activity of ZM447439; (B) in vivo target activity of
Hesperadin. Exponentially growing Calu6 cancer cells were treated with the aurora kinase inhibitors for 1 h at the concentrations indicated. Eﬀects of
the inhibitors on aurora A autophosphorylation at T288 and histone H3 phosphorylation at S10 by aurora B were analyzed by Western blotting
using phospho-speciﬁc antibodies.
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B-dependent checkpoint arrest
Aurora B is a key regulator of spindle checkpoint control.
Pronounced spindle defects in the absence of aurora A may
activate spindle checkpoint. Perhaps cell cycle arrest by lackof aurora A kinase activity is actually a mitotic checkpoint
arrest. To determine if inactivation of aurora A indeed acti-
vates the spindle checkpoint, we analyzed BubR1 phosphory-
lation by Western blotting, because BubR1 is activated by
phosphorylation during checkpoint response [24,25]. As
Fig. 2. Inactivation of aurora B bypasses the requirement for aurora A in mitosis of HeLa cells. (A) Western blot analysis of cells
transfected with siRNAs. (B) Representative cells showing cellular phenotypes after treatment with the siRNAs (a, scramble siRNA; b,
aurora A siRNA; c, aurora B siRNA and d, aurora A + B siRNA). Cells were stained for tubulin (green), phosphor-histone H3 (red) and
DNA (blue). Note monopolar spindles in aurora A siRNA-treated cells and multiple nucleated cells with aurora B siRNA or aurora B and
aurora A siRNA. Bar = 15 lm. (C) Mitotic index of cells treated with the indicated siRNAs. (D) DNA contents of cells treated with the
indicated siRNAs.
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depolymerize microtubules promoted BubR1 phosphoryla-
tion, here seen as the presence of a more slowly migrating
band (Fig. 4). Similarly, inactivation of aurora A with siRNA
also promoted BubR1 phosphorylation (Fig. 4). By contrast,
knockdown of aurora B or double knockdown of aurora A
and B failed to cause BubR1 phosphorylation. The siRNA
knockdown of BubR1 demonstrates that the protein band de-
tected by Western blotting is speciﬁc to BubR1 (Fig. 4). To-
gether, results indicate that inactivation of aurora A indeedactivates spindle checkpoint in an aurora B-dependent man-
ner and that mitotic arrest of cells lacking aurora A is a
checkpoint arrest mediated through aurora B.4. Discussion
In this study, we discovered that aurora B plays a key check-
point role in monitoring completion of mitotic events by aur-




















































































H. Yang et al. / FEBS Letters 579 (2005) 3385–3391 3389aurora A function is compromised. When aurora B is also
inactive, the requirement for aurora A in mitosis is bypassed
and consequently cells are able to progress through mitosis,
leading to polyploidy through DNA endoreduplication in the
absence of cytokinesis.
Aurora A is essential for progression through mitosis
[1–3]. In this study, we found that cells depleted of aurora
A by siRNA were arrested at mitosis. As we only examined
the terminal phenotypes after siRNA treatment, it is thus
possible that cells in the absence of aurora A also had expe-
rienced a G2 delay as previously reported after siRNA treat-
ment during a synchronized cell cycle [5,6] before being
terminally arrested at mitosis. Aurora B is known to play
a critical role in spindle checkpoint arrests in response to ab-
sence of kinetochore/microtubule attachment or lack of ten-
sion resulting from spindle defects [1–3]. It is thus highly
conceivable that spindle defects in cells lacking aurora A
would activate the aurora B-mediated checkpoint, which
may be responsible for cell cycle arrest when aurora A is
inactive. Indeed, inactivation of aurora A activates spindle
checkpoint, indicated by activation of BubR1 checkpoint ki-
nase. By contrast, in the absence of aurora B, inactivation of
aurora A failed to activate BubR1. Together, results indicate
that cell cycle arrest in the absence of aurora A is indeed an
aurora B-mediated checkpoint arrest. However, given its keyrole in spindle checkpoint control, we do not believe that the
checkpoint function over aurora A is the only checkpoint
function of aurora B. Indeed, it is recently reported that
inactivation of aurora B by hesperadin also overrides mitotic
arrest of cells lacking Plk1 [26]. In addition, we further
show that overriding mitotic arrest of cells lacking aurora A
and subsequent DNA polyploidization by inactivation of
aurora B is p53-independent. Normally, p53 checkpoint
function arrests cells at G1 in a tetraploid state when the
preceding mitosis is aberrant, in order to prevent genome
instability [22,23]. How inactivation of aurora B circumvents
this p53-mediated checkpoint function is presently not
understood.
Aurora A kinase is often ampliﬁed or overexpressed in
many types of cancer and increased activity of aurora A is
implicated in tumorigenesis [1–3,8,10]. Indeed, overexpres-
sion of aurora A abrogates spindle checkpoint and promotes
genome instability [8,10,11]. Thus, aurora A represents an
attractive anticancer target for targeted cancer drug discov-
ery [12]. We carried out an aurora A kinase activity-based
screen for aurora A inhibitors and found that a majority
of aurora A inhibitors also have potent activity on aurora
B, hence dual aurora kinase inhibitors. Dual aurora kinase
inhibitors have also been discovered in a similar manner
by others [13–15]. What was puzzling was that treatment
Fig. 3. Inactivation of aurora B bypasses aurora A and causes polyploidy independent of p53. The p53 proﬁcient U2OS cells were treated with
siRNAs and analyzed as described for HeLa cells shown in Fig. 2. (A) Immunoblot analysis of cells transfected with siRNAs; (B) ﬂow cytometry
analysis of cell ploidy.
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nal phenotype consistent with inactivation of aurora B but
not inactivation of aurora A. It was previously thought that
dual aurora kinase inhibitors only have activities on aurora
B in vivo [13]. However, in this study we have demonstrated
that dual aurora kinase inhibitors in fact are active againstboth aurora A and aurora B in vivo. The ﬁnding that aurora
B is responsible for mitotic arrest in the absence of aurora A
thus provides a logical molecular explanation why dual aur-
ora A and aurora B kinase inhibitors generate a terminal
phenotype consistent with loss of aurora B function but
not loss of aurora A.
Fig. 4. Aurora B-dependent activation of BubR1 checkpoint kinase by
inactivation of aurora A. HeLa cells were treated with siRNAs as
described above and the phosphorylation status of BubR1 was analysis
by immunoblotting. Nocodazole treatment is used as a positive
control.
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